Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
14°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NeoGenomics, Inc.
< Previous
1
2
Next >
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
November 19, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
Felicia Williams Joins NeoGenomics Board of Directors
November 14, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 08, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports Third Quarter 2024 Results
November 05, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
October 22, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
October 15, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
October 08, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
September 23, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
September 11, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports Second Quarter 2024 Results
July 29, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
July 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
June 13, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
May 28, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports First Quarter 2024 Results
April 30, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces Senior Leadership Promotions
April 18, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
April 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
March 27, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
March 20, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
March 01, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
February 20, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
February 01, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
January 30, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces Chief Executive Officer Appointment
July 21, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
July 15, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
June 21, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
June 03, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
June 03, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Appoints Lynn Tetrault Interim CEO
May 16, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.